A new pathway for neuroprotection against tau hyperphosphorylation via δ-opioid receptor initiated inhibition of CDK5 and AMPK signaling. [PDF]
Li J, Xu Y, Balboni G, Xia Y.
europepmc +1 more source
Correction: Tabouret et al. TP5, a Peptide Inhibitor of Aberrant and Hyperactive CDK5/p25: A Novel Therapeutic Approach against Glioblastoma. <i>Cancers</i> 2020, <i>12</i>, 1935. [PDF]
Tabouret E +11 more
europepmc +1 more source
ATG9B-4 accelerates the proliferation and migration of liver cancer cells in an ARNTL-CDK5 pathway-dependent manner: A case-control study. [PDF]
Li M +6 more
europepmc +1 more source
From silico to benchtop: cosmosiin as a PD-1/PDL-1 immune checkpoint inhibitor revealed through DFT, network pharmacology analysis, and molecular docking integrated experimental verification. [PDF]
Alsantali RI +9 more
europepmc +1 more source
Correction: Inhibition of CDK5 signaling mediated inflammation in macrophages promotes cutaneous wound healing. [PDF]
Wang J +12 more
europepmc +1 more source
SIRT1 Attenuates Neuropathic Pain via CDK5-Kalirin-7 Signaling Pathway in Type 2 Diabetic Rats. [PDF]
Xie C +8 more
europepmc +1 more source
Erratum in: Vps35 Deficiency Impairs Cdk5/p35 Degradation and Promotes the Hyperphosphorylation of Tau Protein in Retinal Ganglion Cells. [PDF]
europepmc +1 more source
GARD: Genomic Data-Based Drug Repurposing in Head and Neck Cancer with Large Language Model Validation. [PDF]
Tanikella P +8 more
europepmc +1 more source
Blockade of Presynaptic α<sub>2</sub>δ<sub>1-2</sub> Subunits of Voltage-Gated Ca²⁺ Channels Attenuates Neurobiochemical and Sensorimotor Deficits After Traumatic Brain Injury in Mice. [PDF]
Justus JS +14 more
europepmc +1 more source
New progress on the role and mechanism of tau protein in Alzheimer's disease and depression. [PDF]
Wang Y, Zhou J, Zhou Q, Wang H.
europepmc +1 more source

